Genezen Revenue and Competitors

Location

#2507

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Genezen's estimated annual revenue is currently $67.3M per year.(i)
  • Genezen's estimated revenue per employee is $264,843
  • Genezen's total funding is $34M.

Employee Data

  • Genezen has 254 Employees.(i)
  • Genezen grew their employee count by 176% last year.

Genezen's People

NameTitleEmail/Phone
1
Chief Operations OfficerReveal Email/Phone
2
Chief Operations OfficerReveal Email/Phone
3
Head Human Resources (VP)Reveal Email/Phone
4
Director Program ManagementReveal Email/Phone
5
Associate Director Quality AssuranceReveal Email/Phone
6
Associate Director Downstream PD & MSATReveal Email/Phone
7
Senior Manager, MSATReveal Email/Phone
8
Quality Assurance Specialist IIReveal Email/Phone
9
Calibration AdministratorReveal Email/Phone
10
Quality Control Analyst IIReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.8M50%N/AN/A
#2
$7.9M5138%N/AN/A
#3
$13.2M8529%N/AN/A
#4
$2.5M167%$8.16MN/A
#5
$2.5M160%N/AN/A
#6
$8.7M5614%N/AN/A
#7
$0.8M50%N/AN/A
#8
$9.6M625%N/AN/A
#9
$30.8M199-18%N/AN/A
#10
$1.9M1220%N/AN/A
Add Company

What Is Genezen?

As a premier CDMO, we provide GMP viral vector manufacturing, process development, testing, and cell manufacturing to cell & gene therapy companies.

keywords:N/A

$34M

Total Funding

254

Number of Employees

$67.3M

Revenue (est)

176%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Genezen News

2022-04-19 - Genezen fast tracks second phase expansion in US ...

Gene therapy contract development manufacturing organization (CDMO) Genezen Laboratories has completed construction of a 75,000+ square-foot...

2022-04-17 - Genezen Completes Clinical CGMP Manufacturing Facility

Genezen, a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) specializing in lentiviral and retroviral vector...

2022-04-17 - Genezen Completes Facility Buildout

Genezen, a cell and gene therapy CDMO specializing in lentiviral and retroviral vector manufacturing, completed construction of the early...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$48.1M254176%$34M
#2
$68.7M25525%N/A
#3
$91M2563%N/A
#4
$49.5M25716%N/A
#5
$76.9M2599%N/A